Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Anika Therapeutics Inc. (ANIK) had Normalized Pre-Tax Income of $28.56M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$-1.29M |
|
$-21.86M |
|
$-23.86M |
|
$22.57M |
|
$-29.11M |
|
$27.82M |
|
$0.74M |
|
$28.56M |
|
|
Normalized Pre-Tax Income |
$28.56M |
$25.69M |
|
$25.69M |
|
$-21.86M |
|
$25.69M |
|
$27.82M |
|
$26.53M |
|
14.72M |
|
14.72M |
|
$-1.48 |
|
$-1.48 |
|
| Balance Sheet Financials | |
$113.65M |
|
$38.99M |
|
$89.09M |
|
$202.74M |
|
$23.31M |
|
-- |
|
$25.45M |
|
$48.75M |
|
$153.99M |
|
$144.37M |
|
$153.99M |
|
14.42M |
|
| Cash Flow Statement Financials | |
$5.40M |
|
$-8.33M |
|
$-12.73M |
|
$72.87M |
|
$57.16M |
|
$-15.71M |
|
$13.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-1749.22% |
|
-2156.43% |
|
-2156.43% |
|
-- |
|
-2214.11% |
|
1694.96% |
|
$-2.33M |
|
-- |
|
-- |
|
-- |
|
-0.01 |
|
-1.00 |
|
-0.05 |
|
-1646.09 |
|
16.68% |
|
17.80% |
|
12.67% |
|
16.68% |
|
$10.68 |
|
$-0.16 |
|
$0.37 |
|